ATXI — Avenue Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Avenue Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.13	3.76	6.71	1.78	2.59
Net Total Receivables	—	0.09	0	—	—
Prepaid Expenses
Total Current Assets	3.25	3.96	6.84	1.85	2.67
Total Assets	3.25	3.96	6.84	1.85	2.67
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.886	0.509	3.58	1.2	0.816
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	0.886	0.509	2.94	0.268	-0.125
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2.36	3.45	3.9	1.58	2.8
Total Liabilities & Shareholders' Equity	3.25	3.96	6.84	1.85	2.67
Total Common Shares Outstanding
Total Preferred Shares Outstanding